共 20 条
[1]
Garlichs C D,John S,schmeisser A,et al.Upregulation of CD40 ligand( CD154 ) in patients with moderate hypercholesterolemia. Circulation . 2001
[2]
Bruemmer D,Riggers U,Holzmeister J,et al.Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesions. The American Journal of Cardiology . 2001
[3]
Heeschen C,Dimmeler S,Hamm C W,et al.Soluble CD40L in acute coronary syndromes. The New England Journal of Medicine . 2003
[4]
Urbich C,Dernbach E,Aicher A,et al.CD40 ligand inhibits endothelial cell migration by increasing production of endothelial reactive oxygen species. Circulation . 2002
[5]
Henn V,Slupsky J,Grafe M,et al.CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cell. Nature . 1998
[6]
Schonbeck U,Mach F,Galinak,et al.Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture. Circulation Research . 1997
[7]
Schonbeck U,Varo N,Libby P,et al.Soluble CD40L and cardiobascular risk in women. Circulation . 2001
[8]
Mach F,Schonbeck U,Sukhova GK,et al.Functional CD40 ligand is expressed on human vascular endothelial cells,smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proceedings of the National Academy of Sciences of the United States of America . 1997
[9]
Cipollone F,Mezzetti A,Porreca E, et al.Association between enhanced soluble CD40L and prothrombotic Stat e in hypercholesterole mia: effects of statin therapy. Circulation . 2002
[10]
LutgensE,CleutjensKB,HeenemanS.Bothearlyanddelayedanti-CD40Lantibodytreatmentinducesastableplaquephenotype. Proceedings of the National Academy of Sciences of the United States of America . 2000